[Clinical significance of measuring alpha2-plasmin inhibitor levels in kidney diseases].
D000293:Adolescent; D002648:Child; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007674:Kidney Diseases / Q000097:blood* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D009401:Nephrosis / Q000097:blood; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use; D000979:alpha-2-Antiplasmin / Q000032:analysis*
D007136:Immunoglobulins; D000979:alpha-2-Antiplasmin; D006493:Heparin; D014568:Urokinase-Type Plasminogen Activator